Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06362551 · ClinicalTrials.gov registry record
Oocyte Donor Application Discrepancies
A clinical trial, sponsored by Inception Fertility Research Institute.
- Completed
- Registry status
- 600
- Enrollment target
NCT06362551: Completed study, sponsored by Inception Fertility Research Institute.
NCT06362551 is a clinical trial that has completed, run by Inception Fertility Research Institute. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06362551 has completed, sponsored by Inception Fertility Research Institute.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
Retrospective observational study comparing information received on Inception Central Donor Recruitment's standardized online egg donor application compared to information reported during a Genetic Risk Assessment (GRA) consultation with a certified genetic counselor with contracted third party genetic counseling service, GeneScreen. All donor applicants completing a full application with Inception's Central Donor Recruitment and a GRA consultation with GeneScreen will be included.
Primary Outcome
Simple statistical calculations will be evaluated for rate of additional information identified.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2024-04-24 |
What the finished NCT06362551 record still lists
NCT06362551 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06362551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06362551 about?
NCT06362551 is a clinical study titled "Oocyte Donor Application Discrepancies". Retrospective observational study comparing information received on Inception Central Donor Recruitment's standardized online egg donor application compared to information reported during a Genetic Risk Assessment (GRA) consultation with a certified genetic counselor with contracted third party gene...
What is the current status of trial NCT06362551?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2024-03-25. Estimated completion is 2024-04-24.
Who is sponsoring clinical trial NCT06362551?
This trial is sponsored by Inception Fertility Research Institute, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI